Steroid-free immunosuppression with low-dose tacrolimus is safe and significantly reduces the incidence of new-onset diabetes mellitus following liver transplantation

References

• Montori VM, Basu A, Erwin PJ, et al. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care. 2002;25:583–592.
   PubMed Web of Science ®Google Scholar
• Kuo HT, Sampaio MS, Ye X, et al. Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing database. Transplantation. 2010;89:1134–1140.
   PubMed Web of Science ®Google Scholar
• Saliba F, Lakehal M, Pageaux GP, et al. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection: an observational multicenter study. Liver Transpl. 2007;13:136–144.
   PubMed Web of Science ®Google Scholar
• Heisel O, Heisel R, Balshaw R, et al. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant. 2004;4:583–595.
   PubMed Web of Science ®Google Scholar
• Miles AM, Sumrani N, Horowitz R, et al. Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? Transplantation. 1998;65:380–384.
   PubMed Web of Science ®Google Scholar
• Baid S, Cosimi AB, Farrell ML, et al. Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation. 2001;72:1066–1072.
   PubMed Web of Science ®Google Scholar
• Yoo HY, Thuluvath PJ. The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation. Transplantation. 2002;74:1007–1012.
   PubMed Web of Science ®Google Scholar
• Cosio FG, Pesavento TE, Kim S, et al. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int. 2002;62:1440–1446.
   PubMed Web of Science ®Google Scholar
• John PR, Thuluvath PJ. Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transplant. 2002;8:708–713.
   PubMed Web of Science ®Google Scholar
• Kasiske BL, Snyder JJ, Gilbertson D, et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant. 2003;3:178–185.
   PubMed Web of Science ®Google Scholar
• Cosio FG, Kudva Y, van der Velde M, et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int. 2005;67:2415–2421.
   PubMed Web of Science ®Google Scholar
• Hjelmesaeth J, Hartmann A, Leivestad T, et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int. 2006;69:588–595.
   PubMed Web of Science ®Google Scholar
• Moon JI, Barbeito R, Faradji RN, et al. Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: long-term follow up. Transplantation. 2006;82:1625–1628.
   PubMed Web of Science ®Google Scholar
• Foxton MR, Quaglia A, Muiesan P, et al. The impact of diabetes mellitus on fibrosis progression in patients transplanted for hepatitis C. Am J Transplant. 2006;6:1922–1929.
   PubMed Web of Science ®Google Scholar
• Cole EH, Johnston O, Rose CL, et al. Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival. Clin J Am Soc Nephrol: CJASN. 2008;3:814–821.
   PubMed Web of Science ®Google Scholar
• Veldt BJ, Poterucha JJ, Watt KD, et al. Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C. Am J Transplant. 2009;9:1406–1413.
   PubMed Web of Science ®Google Scholar
• Watt KD, Pedersen RA, Kremers WK, et al. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant. 2010;10:1420–1427.
   PubMed Web of Science ®Google Scholar
• Maes BD, Kuypers D, Messiaen T, et al. Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors. Transplant. 2001;72:1655–1661.
   PubMed Web of Science ®Google Scholar
• Khalili M, Lim JW, Bass N, et al. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl. 2004;10:349–355.
   PubMed Web of Science ®Google Scholar
• Rodrigo E, de Cos MA, Fernandez-Fresnedo G, et al. Higher initial tacrolimus blood levels and concentration-dose ratios in kidney transplant recipients who develop diabetes mellitus. Transplant Proc. 2005;37:3819–3820.
   PubMed Web of Science ®Google Scholar
• Rodrigo E, Pinera C, de Cos MA, et al. Evolution of tacrolimus blood levels and concentration-dose ratios in patients who develop new onset diabetes mellitus after kidney transplantation. Transplant Int. 2005;18:1152–1157.
   PubMed Web of Science ®Google Scholar
• Chen T, Jia H, Li J, et al. New onset diabetes mellitus after liver transplantation and hepatitis C virus infection: meta-analysis of clinical studies. Transplant Int: official J Eur Soc Organ Transplant. 2009;22:408–415.
   PubMed Web of Science ®Google Scholar
• Watt K, Veldt B, Charlton M. A practical guide to the management of HCV infection following liver transplantation. Am J Transplant. 2009;9:1707–1713.
   PubMed Web of Science ®Google Scholar
• Arner P, Gunnarsson R, Blomdahl S, et al. Some characteristics of steroid diabetes: a study in renal-transplant recipients receiving high-dose corticosteroid therapy. Diabetes Care. 1983;6:23–25.
   PubMed Web of Science ®Google Scholar
• David DS, Cheigh JS, Braun DW Jr, et al. HLA-A28 and steroid-induced diabetes in renal transplant patients. JAMA. 1980;243:532–533.
   PubMed Web of Science ®Google Scholar
• Friedman EA, Shyh TP, Beyer MM, et al. Posttransplant diabetes in kidney transplant recipients. Am J Nephrol. 1985;5:196–202.
   PubMed Web of Science ®Google Scholar
• Lerut JP. Avoiding steroids in solid organ transplantation. Transplant Int. 2003;16:213–224.
   PubMed Web of Science ®Google Scholar
• Eason JD, Loss GE, Blazek J, et al. Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial. Liver Transplant. 2001;7:693–697.
   PubMed Web of Science ®Google Scholar
• Segev DL, Sozio SM, Shin EJ, et al. Steroid avoidance in liver transplantation: meta-analysis and meta-regression of randomized trials. Liver Transpl. 2008;14:512–525.
   PubMed Web of Science ®Google Scholar
• O’Grady JG. Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy. Liver Transpl. 2004;10:327–328.
   PubMedGoogle Scholar
• American DA. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27(Suppl 1):S5–S10.
   PubMedGoogle Scholar
• Aberg F, Gissler M, Karlsen TH, et al. Differences in long-term survival among liver transplant recipients and the general population: a population-based Nordic study. Hepatology. 2015;61:668–677.
   PubMed Web of Science ®Google Scholar
• Marubashi S, Umeshita K, Asahara T, et al. Steroid-free living donor liver transplantation for HCV–a multicenter prospective cohort study in Japan. Clin Transplant. 2012;26:857–867.
   PubMed Web of Science ®Google Scholar
• Klintmalm GB, Davis GL, Teperman L, et al. A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl. 2011;17:1394–1403.
   PubMed Web of Science ®Google Scholar
• Ramirez CB, Doria C, Frank AM, et al. Completely steroid-free immunosuppression in liver transplantation: a randomized study. Clin Transplant. 2013;27:463–471.
   PubMed Web of Science ®Google Scholar
• Redmon JB, Olson LK, Armstrong MB, et al. Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J Clin Invest. 1996;98:2786–2793.
   PubMed Web of Science ®Google Scholar
• Boots JM, van Duijnhoven EM, Christiaans MH, et al. Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction. J Am Soc Nephrol. 2002;13:221–227.
   PubMed Web of Science ®Google Scholar
• van Hooff JP, Christiaans MH, van DEM. Evaluating mechanisms of post-transplant diabetes mellitus. Nephrol Dial Transplant. 2004;19(Suppl 6):vi8–vi12.
   PubMed Web of Science ®Google Scholar
• Webster AC, Woodroffe RC, Taylor RS, et al. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ. 2005;331:810.
   PubMed Web of Science ®Google Scholar
• Caronia S, Taylor K, Pagliaro L, et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology. 1999;30:1059–1063.
   PubMed Web of Science ®Google Scholar
• Mason AL, Lau JY, Hoang N, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology. 1999;29:328–333.
   PubMed Web of Science ®Google Scholar
• Lecube A, Hernandez C, Genesca J, et al. High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury. Diabetes Care. 2004;27:1171–1175.
   PubMed Web of Science ®Google Scholar
• Romero-Gomez M, Del Mar Viloria M, Andrade RJ, et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology. 2005;128:636–641.
   PubMed Web of Science ®Google Scholar
• Xing T, Huang L, Yu Z, et al. Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma. PLoS One. 2013;8:e71251.
   PubMed Web of Science ®Google Scholar
• Tisone PTJrKG. Preserving renal function with prolonged-release tacrolimus-based immunosuppression in de novo liver transplantation: Initial results from the DIAMOND study. ESOT; 2013-09-11; Vienna 2013.
   Google Scholar
• TruneČka P, Klempnauer J, Bechstein WO, DIAMOND† study group, et al. Renal function in de novo liver transplant recipients receiving different prolonged-release tacrolimus regimens-the DIAMOND Study. Am J Transplant. 2015;15:1843–1854.
   PubMed Web of Science ®Google Scholar